Eton Pharmaceuticals Analyst Ratings
Eton Pharmaceuticals Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 284.62% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 07/03/2023 | 246.15% | HC Wainwright & Co. | $10 → $9 | Maintains | Buy |
| 03/21/2023 | 284.62% | HC Wainwright & Co. | → $10 | Reiterates | → Buy |
| 09/26/2022 | 284.62% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 07/25/2022 | 246.15% | HC Wainwright & Co. | $11 → $9 | Maintains | Buy |
| 03/22/2022 | 323.08% | HC Wainwright & Co. | $14 → $11 | Maintains | Buy |
| 03/17/2021 | 438.46% | HC Wainwright & Co. | $15 → $14 | Maintains | Buy |
| 01/04/2021 | 476.92% | HC Wainwright & Co. | $20 → $15 | Maintains | Buy |
| 09/30/2020 | 669.23% | HC Wainwright & Co. | $18 → $20 | Maintains | Buy |
| 05/26/2020 | 592.31% | HC Wainwright & Co. | $26 → $18 | Maintains | Buy |
| 05/15/2020 | 284.62% | B. Riley Securities | $12 → $10 | Maintains | Buy |
| 03/30/2020 | 900% | HC Wainwright & Co. | $23 → $26 | Reiterates | → Buy |
| 01/28/2020 | 784.62% | HC Wainwright & Co. | $21 → $23 | Reiterates | → Buy |
| 10/23/2019 | 707.69% | HC Wainwright & Co. | $18 → $21 | Reiterates | → Buy |
| 09/20/2019 | 419.23% | B. Riley Securities | → $13.5 | Initiates Coverage On | → Buy |
| 06/10/2019 | 476.92% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 08/11/2023 | 284.62% | HC Wainwright & Co. | 9 美元 → 10 美元 | 維護 | 購買 |
| 07/03/2023 | 246.15% | HC Wainwright & Co. | 10 美元 → 9 美元 | 維護 | 購買 |
| 03/21/2023 | 284.62% | HC Wainwright & Co. | → 10 美元 | 重申 | → 購買 |
| 09/26/2022 | 284.62% | HC Wainwright & Co. | 9 美元 → 10 美元 | 維護 | 購買 |
| 2022 年 7 月 25 日 | 246.15% | HC Wainwright & Co. | 11 美元 → 9 美元 | 維護 | 購買 |
| 03/22/2022 | 323.08% | HC Wainwright & Co. | 14 美元 → 11 美元 | 維護 | 購買 |
| 2021 年 3 月 17 日 | 438.46% | HC Wainwright & Co. | 15 美元 → 14 美元 | 維護 | 購買 |
| 01/04/2021 | 476.92% | HC Wainwright & Co. | 20 美元 → 15 美元 | 維護 | 購買 |
| 09/30/2020 | 669.23% | HC Wainwright & Co. | 18 美元 → 20 美元 | 維護 | 購買 |
| 2020 年 5 月 26 日 | 592.31% | HC Wainwright & Co. | 26 美元 → 18 美元 | 維護 | 購買 |
| 05/15/2020 | 284.62% | B. 萊利證券 | 12 美元 → 10 美元 | 維護 | 購買 |
| 2020 年 3 月 30 日 | 900% | HC Wainwright & Co. | 23 美元 → 26 美元 | 重申 | → 購買 |
| 2020 年 1 月 28 日 | 784.62% | HC Wainwright & Co. | 21 美元 → 23 美元 | 重申 | → 購買 |
| 2019 年 10 月 23 日 | 707.69% | HC Wainwright & Co. | 18 美元 → 21 美元 | 重申 | → 購買 |
| 09/20/2019 | 419.23% | B. 萊利證券 | → 13.5 美元 | 啓動覆蓋開啓 | → 購買 |
| 2019 年 10 月 6 日 | 476.92% | HC Wainwright & Co. | → 15 美元 | 啓動覆蓋開啓 | → 購買 |
What is the target price for Eton Pharmaceuticals (ETON)?
伊頓製藥（ETON）的目標價格是多少？
The latest price target for Eton Pharmaceuticals (NASDAQ: ETON) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $10.00 expecting ETON to rise to within 12 months (a possible 284.62% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年8月11日公佈了伊頓製藥（納斯達克股票代碼：ETON）的最新目標股價。這家分析公司將目標股價定爲10.00美元，預計ETON將在12個月內升至10.00美元（可能上漲284.62％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Eton Pharmaceuticals (ETON)?
伊頓製藥（ETON）的最新分析師評級是多少？
The latest analyst rating for Eton Pharmaceuticals (NASDAQ: ETON) was provided by HC Wainwright & Co., and Eton Pharmaceuticals maintained their buy rating.
伊頓製藥（納斯達克股票代碼：ETON）的最新分析師評級由HC Wainwright & Co. 提供，伊頓製藥維持買入評級。
When is the next analyst rating going to be posted or updated for Eton Pharmaceuticals (ETON)?
伊頓製藥（ETON）的下一個分析師評級何時公佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eton Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eton Pharmaceuticals was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與伊頓製藥的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應該獲得4個評級。伊頓製藥公司的最後一次評級是在2023年8月11日提交的，因此您應該預計下一個評級將在2024年8月11日左右公佈。
Is the Analyst Rating Eton Pharmaceuticals (ETON) correct?
分析師對伊頓製藥（ETON）的評級正確嗎？
While ratings are subjective and will change, the latest Eton Pharmaceuticals (ETON) rating was a maintained with a price target of $9.00 to $10.00. The current price Eton Pharmaceuticals (ETON) is trading at is $2.60, which is out of the analyst's predicted range.
儘管評級是主觀的，將會發生變化，但最新的伊頓製藥（ETON）評級維持不變，目標股價爲9.00美元至10.00美元。伊頓製藥（ETON）目前的交易價格爲2.60美元，超出了分析師的預測區間。
譯文內容由第三人軟體翻譯。